Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 40, Issue 3, 1991, Pages 229-231

  Pons, J C ^a   Taburet, A M ^b   Singlas, E ^b   Delfraissy, J F ^a   Papiernik, E ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Azathiothymidine (AZT); Fetal blood sampling; Human immunodeficiency virus; Materno fetal transmission; Pregnancy

Indexed keywords

DRUG METABOLITE; ZIDOVUDINE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORAL DRUG ADMINISTRATION; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; FETAL BLOOD; HUMAN; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIDOVUDINE;

EID: 0025872418     PISSN: 00282243     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-2243(91)90122-2     Document Type: Article

References (7)

1. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases
2. The assessment of fetal blood samples
3. Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography
4. Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV-seropositive patients
5. Prenatal toxicity of zudovudine in rats
6. Fetoplacental passage of zidovudine
7. New procedure for fetal blood sampling during pregnancy applying to prenatal pharmacology